Previous close | 33.30 |
Open | 33.70 |
Bid | 33.86 x 200 |
Ask | 33.94 x 100 |
Day's range | 33.03 - 33.95 |
52-week range | 18.61 - 39.26 |
Volume | |
Avg. volume | 402,667 |
Market cap | 1.926B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 14.62 |
EPS (TTM) | 2.32 |
Earnings date | 06 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 43.63 |
Harmony Biosciences Holdings' (NASDAQ:HRMY) stock is up by a considerable 15% over the past three months. Given the...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2024 financial results on Tuesday, August 6, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on August 6, 2024, at 8:30 a.m. ET to discuss the results.
HRMY vs. REGN: Which Stock Is the Better Value Option?